Participated · Equity · Jul 2026

Otrera develops a sodium-cooled fast-neutron reactor (RNR-Na) design derived from CEA research and adapted with recent industrial advances. Its RNR-Na technology is intended to enable repeated use of reprocessed nuclear fuel, supporting a closed fuel cycle that reduces ultimate waste volumes and lessens the need for natural uranium extraction. With the newly announced €17 million financing—partly from France 2030 and partly from a private round including EDF, ADF, Onet Technologies, Exergon and Normandie Participations—the company is entering an advanced engineering phase. Otrera will use the funds to carry out its Avant-Projet Détaillé (APD), develop test capabilities, hire staff, and structure its supply chain. The company has announced plans to site a future industrial facility near Cherbourg (Manche) to prepare manufacturing and assembly of critical components for serial reactor deployment.

Participated · Equity · Apr 2026

Cap atlas specialises in acquisition and analysis of geospatial data collected by drones and develops a cartographic application called Tesseract. The company is headquartered in Ganzeville. It recently raised €1.1M to scale its operations, continue product development and speed up the commercial rollout of Tesseract. The round brought in regional investors including Normandie Participations, Normandie Littoral and Normandie Business Angels alongside historical partner Crédit Agricole Innove en Normandie. The financing is intended to help the company change scale and accelerate market development.

Participated · Equity · Dec 2025

Founded in 2019, Veragrow uses a proprietary extraction and stabilization process to isolate active compounds generated by more than 25 million earthworms converting agricultural co-products into high-value lombricompost. The resulting plant-based biostimulant formulations have demonstrated strong agronomic performance in over 930 field trials across crops such as wheat, maize, potatoes, sugar beet, oilseed rape, flax, vineyards, and vegetables. By 2025 the company had built a distribution network of 30+ partners in France and initiated field trials in more than 20 countries, including Denmark, Morocco, Brazil, and Senegal. Operating from an integrated R&D, production, and commercialization hub in Val-de-Reuil, Veragrow collaborates with institutions like INRAE, CNRS, UniLaSalle, and GlycoMev. The new capital injection will fund expansion of production capacity, reinforcement of its sales network, and acceleration of R&D, with six additional formulations slated for launch in 2026. Veragrow aims to become a leading global manufacturer of bio-based biostimulants by 2030.

Participated · Equity · Nov 2025

Created by Caen-based startup Doctizy in October 2021, Klodios combines real-time information monitoring with collaborative tools tailored to life-science and healthcare teams. Its platform is already used by major industry players such as GlaxoSmithKline, Vertex, Sanofi and ViiV Healthcare, and a pilot collaboration has begun with the ARS de La Réunion. After two years building an initial product and two additional years refining its technical and strategic roadmap, the company is now focused on delivering a second-generation version of Klodios. The newly secured financing will fund expanded R&D, including the hiring of five additional AI engineers in 2026 and three customer-success specialists. Founders Nicolas and Clément Vivet, joined by engineer Steve Gendarme, continue to lead product development. While financial metrics such as revenue or user counts were not disclosed, the presence of blue-chip pharma clients suggests early commercial traction. The company positions its technology as a critical workflow and knowledge-management layer within the healthcare ecosystem.

Participated · Equity · Aug 2025

Delivrone designs and operates drone transport services for the medical sector, transferring biological samples, treatments, and emergency equipment between hospitals and laboratories. The company inaugurated what it describes as the first regular European drone link for medicine and has installed a dedicated drone landing area at Hôpital de Verneuil‑sur‑Avre. Founded in 2021 in Saint-Étienne-du-Rouvray in the Rouen metropolitan area, Delivrone builds its own supervision software and ground equipment for operations. The startup plans to strengthen its teams, consolidate infrastructure, and multiply aerial routes in partnership with regional hospital networks. It also intends to further develop its in-house technological tools and extend its presence to new territories.